Table 1.
Secondary Outcome Measures
| Secondary outcome measures (6 months and 12 months post initiation of HAART) | Type |
| Health outcomes | |
| Self-reported adherence as a percentage | Binary |
| Suppressed HIV viral load (in copies) | Continuous |
| Immune reconstitution (change in CD4 T cell count from baseline) | |
| Time to virological failure | Continuous |
| Weight gain [lbs] and BMI | Time-to-event |
| Occurrence of opportunistic infections (OIs) | Continuous |
| Time to reporting of adverse drug events (ADEs) | Binary |
| Deaths (all cause) | Time-to-event |
| Quality of life (QOL) | Time-to-event |
| SF-12 | |
| Satisfaction with care provided | Continuous |
| Social factors | Continuous |
| Level of disclosure of HIV status | |
| Impression of stigma | Binary |
| Family dyamics | Continuous |
| Economic factors | Continuous |
| Employment attendance | |
| Household member school attendance | Continuous |
| Cell phones lost/stolen | Continuous |
HAART = highly active antiretroviral therapy, SF-12 = short form 12 adapted for regional application in Kiswahili.